Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation Crespo, M. M., Lease, E. D., Sole, A., Sandorfi, N., Snyder, L. D., Berry, G. J., Pavec, J. L., Venado, A. E., Cifrian, J. M., Goldberg, H., Dilling, D. F., Gries, C., Nair, A., Willie, K., Meyer, K. C., Shah, R. J., Tokman, S., Holm, A., Patterson, C. M., McWilliams, T., Shtraichman, O., Bemiss, B., Salgado, J., Farver, C., Strah, H., Wassilew, K., Kaza, V., Howsare, M., Murray, M., Bhorade, S., Budev, M. 2021

Abstract

Patients with connective tissue disease (CTD) and advanced lung disease are often considered suboptimal candidates for lung transplantation (LTx) due to their underlying medical complexity and potential surgical risk. There is substantial variability across LTx centers regarding the evaluation and listing of these patients. The International Society for Heart and Lung Transplantation-supported consensus document on lung transplantation in patients with CTD standardization aims to clarify definitions of each disease state included under the term CTD, to describe the extrapulmonary manifestations of each disease requiring consideration before transplantation, and to outline the absolute contraindications to transplantation allowing risk stratification during the evaluation and selection of candidates for LTx.

View details for DOI 10.1016/j.healun.2021.07.014

View details for PubMedID 34417111